We believe that non-GAAP financial measures can provide useful information to both management and investors by excluding certain non-cash and other one-time expenses that are not indicative of our core operating results. Among other uses, our management uses non-GAAP measures to compare our performance relative to forecasts and strategic plans and to benchmark our performance externally against competitors. In addition, management’s incentive compensation will be determined in part using these non-GAAP measures because we believe non-GAAP measures better reflect our core operating performance.
The following are explanations of each type of adjustment that we incorporate into non-GAAP financial measures:
Stock-based compensation expense relates to equity incentive awards granted to our employees, directors, and consultants. Our equity incentive plans are important components of our employee incentive compensation arrangements and are reflected as expenses in our GAAP results. Stock-based compensation expense has been and will continue to be a significant recurring expense for MaxLinear. In addition, we exclude the related tax effect of stock-based compensation expense, if any, from non-GAAP net income.
Bonus payments under our executive and non-executive bonus programs have been excluded from our non-GAAP net income for 2015 and 2014. Bonus payments for the 2014 and first half of the 2015 performance periods were settled through the issuance of shares of Class A common stock under our equity incentive plans in May and August 2015, and we currently expect that any bonus payments under our 2015 programs for the second half of 2015 will also be settled in Class A common stock. While we include the dilutive impact of equity awards in weighted average shares outstanding, the expense associated with stock-based awards reflects a non-cash charge that we exclude from non-GAAP net income.
Restricted stock units to be granted under our equity incentive plan to Physpeed continuing employees if certain 2015 and 2016 revenue targets are met contingent upon continued employment reflect a non-cash charge that we exclude from non-GAAP net income.
Expenses incurred in relation to acquisitions include amortization of purchased intangible assets, amortization of inventory step-up, acquisition and integration costs primarily consisting of professional and consulting fees, restricted merger proceeds which represent merger proceeds held back from the former principal shareholders of Physpeed which will be paid on a quarterly basis through October 31, 2016 and the change in fair value of contingent consideration.
Restructuring charges incurred are related to our restructuring plan which addresses issues primarily relating to the integration of the Company and Entropic businesses. Severance charges incurred relate primarily to our exit of research and development activities in Shanghai, China and other non-recurring charges related to the termination of employees.
Expenses incurred in relation to impairment of production masks reflect costs that were previously capitalized but for which future use is no longer expected.
Expenses incurred in relation to our intellectual property litigation include professional fees incurred.
The acquisition of Entropic resulted in a net deferred tax liability, which led to the release of valuation allowance and a benefit (provision) for income taxes.
Reconciliations of non-GAAP measures disclosed in this press release appear below.
About MaxLinear, Inc.
MaxLinear, Inc. is a provider of integrated, radio-frequency (RF) and mixed-signal integrated circuits for broadband communications, pay-TV and the connected home, and data center, metro, and long-haul transport network applications. MaxLinear is located in Carlsbad, California, and its address on the Internet is www.maxlinear.com.
MXL is MaxLinear’s registered trademark. Other trademarks appearing herein are the property of their respective owners.
MAXLINEAR, INC.
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
Three Months Ended | |||||||||||
September 30, 2015 (1) | June 30, 2015 (2) | September 30, 2014 | |||||||||
Net revenue | $ | 95,191 | $ | 70,824 | $ | 32,541 | |||||
Cost of net revenue | 44,141 | 43,882 | 12,632 | ||||||||
Gross profit | 51,050 | 26,942 | 19,909 | ||||||||
Operating expenses: | |||||||||||
Research and development | 23,491 | 23,993 | 14,957 | ||||||||
Selling, general and administrative | 25,457 | 23,620 | 8,141 | ||||||||
Restructuring charges | 425 | 11,389 | — | ||||||||
Total operating expenses | 49,373 | 59,002 | 23,098 | ||||||||
Income (loss) from operations | 1,677 | (32,060 | ) | (3,189 | ) | ||||||
Interest income | 47 | 51 | 61 | ||||||||
Other income (expense), net | 407 | (22 | ) | (49 | ) | ||||||
Income (loss) before income taxes | 2,131 | (32,031 | ) | (3,177 | ) | ||||||
Provision (benefit) for income taxes | 549 | (1,384 | ) | 28 | |||||||
Net income (loss) | $ | 1,582 | $ | (30,647 | ) | $ | (3,205 | ) | |||
Net income (loss) per share: | |||||||||||
Basic | $ | 0.03 | $ | (0.58 | ) | $ | (0.09 | ) | |||
Diluted | $ | 0.03 | $ | (0.58 | ) | $ | (0.09 | ) | |||
Shares used to compute net income (loss) per share: | |||||||||||
Basic | 60,644 | 52,586 | 36,901 | ||||||||
Diluted | 63,209 | 52,586 | 36,901 |